Detection and clinical significance of circulating tumor cells in colorectal cancer

Abstract Histopathological examination (biopsy) is the “gold standard” for the diagnosis of colorectal cancer (CRC). However, biopsy is an invasive method, and due to the temporal and spatial heterogeneity of the tumor, a single biopsy cannot reveal the comprehensive biological characteristics and d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Miao Jiang, Shuiling Jin, Jinming Han, Tong Li, Jianxiang Shi, Qian Zhong, Wen Li, Wenxue Tang, Qinqin Huang, Hong Zong
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/ea00455f49d44dd2a442fc24c062e4e7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ea00455f49d44dd2a442fc24c062e4e7
record_format dspace
spelling oai:doaj.org-article:ea00455f49d44dd2a442fc24c062e4e72021-11-21T12:06:43ZDetection and clinical significance of circulating tumor cells in colorectal cancer10.1186/s40364-021-00326-42050-7771https://doaj.org/article/ea00455f49d44dd2a442fc24c062e4e72021-11-01T00:00:00Zhttps://doi.org/10.1186/s40364-021-00326-4https://doaj.org/toc/2050-7771Abstract Histopathological examination (biopsy) is the “gold standard” for the diagnosis of colorectal cancer (CRC). However, biopsy is an invasive method, and due to the temporal and spatial heterogeneity of the tumor, a single biopsy cannot reveal the comprehensive biological characteristics and dynamic changes of the tumor. Therefore, there is a need for new biomarkers to improve CRC diagnosis and to monitor and treat CRC patients. Numerous studies have shown that “liquid biopsy” is a promising minimally invasive method for early CRC detection. A liquid biopsy mainly samples circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), microRNA (miRNA) and extracellular vesicles (EVs). CTCs are malignant cells that are shed from the primary tumors and/or metastases into the peripheral circulation. CTCs carry information on both primary tumors and metastases that can reflect dynamic changes in tumors in a timely manner. As a promising biomarker, CTCs can be used for early disease detection, treatment response and disease progression evaluation, disease mechanism elucidation, and therapeutic target identification for drug development. This review will discuss currently available technologies for plasma CTC isolation and detection, their utility in the management of CRC patients and future research directions.Miao JiangShuiling JinJinming HanTong LiJianxiang ShiQian ZhongWen LiWenxue TangQinqin HuangHong ZongBMCarticleColorectal CancerCirculating tumor cellCellular heterogeneityPrecision medicineSeparationTherapeutics. PharmacologyRM1-950ENBiomarker Research, Vol 9, Iss 1, Pp 1-20 (2021)
institution DOAJ
collection DOAJ
language EN
topic Colorectal Cancer
Circulating tumor cell
Cellular heterogeneity
Precision medicine
Separation
Therapeutics. Pharmacology
RM1-950
spellingShingle Colorectal Cancer
Circulating tumor cell
Cellular heterogeneity
Precision medicine
Separation
Therapeutics. Pharmacology
RM1-950
Miao Jiang
Shuiling Jin
Jinming Han
Tong Li
Jianxiang Shi
Qian Zhong
Wen Li
Wenxue Tang
Qinqin Huang
Hong Zong
Detection and clinical significance of circulating tumor cells in colorectal cancer
description Abstract Histopathological examination (biopsy) is the “gold standard” for the diagnosis of colorectal cancer (CRC). However, biopsy is an invasive method, and due to the temporal and spatial heterogeneity of the tumor, a single biopsy cannot reveal the comprehensive biological characteristics and dynamic changes of the tumor. Therefore, there is a need for new biomarkers to improve CRC diagnosis and to monitor and treat CRC patients. Numerous studies have shown that “liquid biopsy” is a promising minimally invasive method for early CRC detection. A liquid biopsy mainly samples circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), microRNA (miRNA) and extracellular vesicles (EVs). CTCs are malignant cells that are shed from the primary tumors and/or metastases into the peripheral circulation. CTCs carry information on both primary tumors and metastases that can reflect dynamic changes in tumors in a timely manner. As a promising biomarker, CTCs can be used for early disease detection, treatment response and disease progression evaluation, disease mechanism elucidation, and therapeutic target identification for drug development. This review will discuss currently available technologies for plasma CTC isolation and detection, their utility in the management of CRC patients and future research directions.
format article
author Miao Jiang
Shuiling Jin
Jinming Han
Tong Li
Jianxiang Shi
Qian Zhong
Wen Li
Wenxue Tang
Qinqin Huang
Hong Zong
author_facet Miao Jiang
Shuiling Jin
Jinming Han
Tong Li
Jianxiang Shi
Qian Zhong
Wen Li
Wenxue Tang
Qinqin Huang
Hong Zong
author_sort Miao Jiang
title Detection and clinical significance of circulating tumor cells in colorectal cancer
title_short Detection and clinical significance of circulating tumor cells in colorectal cancer
title_full Detection and clinical significance of circulating tumor cells in colorectal cancer
title_fullStr Detection and clinical significance of circulating tumor cells in colorectal cancer
title_full_unstemmed Detection and clinical significance of circulating tumor cells in colorectal cancer
title_sort detection and clinical significance of circulating tumor cells in colorectal cancer
publisher BMC
publishDate 2021
url https://doaj.org/article/ea00455f49d44dd2a442fc24c062e4e7
work_keys_str_mv AT miaojiang detectionandclinicalsignificanceofcirculatingtumorcellsincolorectalcancer
AT shuilingjin detectionandclinicalsignificanceofcirculatingtumorcellsincolorectalcancer
AT jinminghan detectionandclinicalsignificanceofcirculatingtumorcellsincolorectalcancer
AT tongli detectionandclinicalsignificanceofcirculatingtumorcellsincolorectalcancer
AT jianxiangshi detectionandclinicalsignificanceofcirculatingtumorcellsincolorectalcancer
AT qianzhong detectionandclinicalsignificanceofcirculatingtumorcellsincolorectalcancer
AT wenli detectionandclinicalsignificanceofcirculatingtumorcellsincolorectalcancer
AT wenxuetang detectionandclinicalsignificanceofcirculatingtumorcellsincolorectalcancer
AT qinqinhuang detectionandclinicalsignificanceofcirculatingtumorcellsincolorectalcancer
AT hongzong detectionandclinicalsignificanceofcirculatingtumorcellsincolorectalcancer
_version_ 1718419278917533696